Viewing Study NCT00899795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:59 PM
Ignite Modification Date: 2025-12-28 @ 2:53 PM
Study NCT ID: NCT00899795
Status: COMPLETED
Last Update Posted: 2017-12-04
First Post: 2009-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers
Sponsor: OHSU Knight Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None recurrent adult acute myeloid leukemia View
None secondary acute myeloid leukemia View
None secondary myelodysplastic syndromes View
None untreated adult acute myeloid leukemia View
None childhood myelodysplastic syndromes View